Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.90
-0.2689-0.79%
Volume:4K
Turnover:149.39K
Market Cap:13.56M
PE:- -
High:34.04
Open:34.00
Low:33.90
Close:34.17
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:8.27
T/O Rate:1.10%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck price target raised to $161 from $127 at Leerink

TIPRANKS
·
Sep 09

Genfit Targets Billion‑Dollar MASH Diagnostics Market With NISTM Blood Tests

TIPRANKS
·
Sep 09

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program with Gilead

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Assembly Bio Highlights Phase 2 Starts for ABI-6250, GS-1179 in Pipeline Update

Reuters
·
Sep 09

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Reuters
·
Sep 09

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for Hsv Helicase-Primase Inhibitor Program

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Assembly Bio Eligible for up to $280 Mln in Milestones and Royalties Outside U.S.

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gs-1179 Expected to Advance into Phase 2 Trial for Genital Herpes by End of 2026

THOMSON REUTERS
·
Sep 09

Assembly Biosciences - Gilead Retains Sole Right for Clinical Development and Commercialization of Hsv Hpi Program

THOMSON REUTERS
·
Sep 09

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Sep 09

ABL Diagnostics Delivers Surging Profits as Scale‑Up Strategy Takes Hold

TIPRANKS
·
Sep 09

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Sep 09

AstraZeneca's COPD Candidate Shows Strong Results in Late-Stage Trials, Reviving a Once-Doubted Drug Target

Deep News
·
Sep 08

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Dow Jones
·
Sep 08

Video: Novartis slides after second recent drug development setback

TIPRANKS
·
Sep 08